| ISIN | CH0368915242 |
|---|---|
| Valor Number | 36891524 |
| Bloomberg Global ID | |
| Fund Name | GENERALI Equity Fund Switzerland B |
| Fund Provider |
Generali Investments Schweiz AG
Soodmattenstrasse 2 8134 Adliswil 1 E-Mail: headoffice.ch@generali-invest.com Web: www.generali.ch/investments |
| Fund Provider | Generali Investments Schweiz AG |
| Representative in Switzerland | |
| Distributor(s) |
Generali Holding AG Adliswil Phone: +41 58 472 44 44 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 342.29 CHF | 30.12.2025 |
|---|---|---|
| Previous Price * | 341.62 CHF | 29.12.2025 |
| 52 Week High * | 342.29 CHF | 30.12.2025 |
| 52 Week Low * | 275.56 CHF | 09.04.2025 |
| NAV * | 342.29 CHF | 30.12.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 57,487,131 | |
| Unit/Share Assets *** | 50,409 | |
| Trading Information SIX | ||
| YTD Performance | +17.17% |
30.12.2024 - 30.12.2025
30.12.2024 30.12.2025 |
|---|---|---|
| 1 month | +3.22% |
01.12.2025 - 30.12.2025
01.12.2025 30.12.2025 |
| 3 months | +8.85% |
30.09.2025 - 30.12.2025
30.09.2025 30.12.2025 |
| 6 months | +9.96% |
30.06.2025 - 30.12.2025
30.06.2025 30.12.2025 |
| 1 year | +17.17% |
30.12.2024 - 30.12.2025
30.12.2024 30.12.2025 |
| 2 years | +24.65% |
03.01.2024 - 30.12.2025
03.01.2024 30.12.2025 |
| 3 years | +31.43% |
30.12.2022 - 30.12.2025
30.12.2022 30.12.2025 |
| 5 years | +37.13% |
30.12.2020 - 30.12.2025
30.12.2020 30.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 13.10% | |
|---|---|---|
| Novartis AG Registered Shares | 12.54% | |
| Nestle SA | 11.39% | |
| UBS Group AG Registered Shares | 5.75% | |
| Zurich Insurance Group AG | 5.12% | |
| Compagnie Financiere Richemont SA Class A | 4.74% | |
| ABB Ltd | 4.02% | |
| Sandoz Group AG Registered Shares | 2.91% | |
| Lonza Group Ltd | 2.87% | |
| Alcon Inc | 2.78% | |
| Last data update | 30.11.2025 | |
| TER | 0.00% |
|---|---|
| TER date | 30.09.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.50% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |